Didier Laureillard

10PUBLICATIONS
47CO-AUTHORS
Respiratory diseasesBehavioural epidemiologyMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 16, 2025
Histoplasma Antigenuria Prevalence in Patients With Advanced HIV Disease in Côte d'Ivoire: A Prospective Trial Ancillary Study.

Aude Sturny-Leclère, Ugo Françoise, Anani D Badjé

|Apr 24, 2025
What Is the Optimal Community-Based Tuberculosis Screening Algorithm for People Who Inject Drugs in a High-Burden Setting?

Morgana D'Ottavi, Hong Thi Tran, Hai Nguyen

|Nov 24, 2023
HCV RNA Quantification by a Domestic Commercial Assay: A Case Study among People Who Inject Drugs in Vietnam.

Quynh Bach Thi Nhu, Linh Le Thi Thuy, Hong Thi Nguyen

|Oct 27, 2023
Natural Killer Repertoire Restoration in TB/HIV Co-Infected Individuals Experienced an Immune Reconstitution Syndrome (CAMELIA Trial, ANRS 12153).

Polidy Pean, Yoann Madec, Eric Nerrienet

|Jan 21, 2023
Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France.

Paul Laffont-Lozes, Didier Laureillard, Paul Loubet

|Oct 27, 2022
Long-Term Persistence of Mitochondrial DNA Instability among HCV-Cured People Who Inject Drugs.

Mélusine Durand, Nicolas Nagot, Quynh Bach Thi Nhu

Pageof 2

Frequent Collaborators

5 joint publications

Vu Hai Vinh

4 joint publications

Pham Minh Khue

4 joint publications

Roselyne Vallo

4 joint publications

Jean-Pierre Moles